MBrace Therapeutics

San Diego, United States

MBrace Therapeutics is a privately held biopharmaceutical business.

$85.0M raised

Nov 2023

Series B

Biotechnology

Top Investors

TPGVenrockAvidity PartnersAlta PartnersCowen Healthcare Investments

Founder Contacts

19,000+ verified contacts

Get Instant Access

Emails, phones & LinkedIn profiles

Frequently Asked Questions about MBrace Therapeutics

How much funding has MBrace Therapeutics raised?

MBrace Therapeutics has raised $85.0M in total funding. The most recent round was Series B. The last funding was announced in November 2023.

Who are MBrace Therapeutics's investors?

MBrace Therapeutics's investors include TPG, Venrock, Avidity Partners, Alta Partners, Cowen Healthcare Investments.

Where is MBrace Therapeutics headquartered?

MBrace Therapeutics is headquartered in San Diego, United States.

What does MBrace Therapeutics do?

MBrace Therapeutics is a privately held biopharmaceutical business.

What stage is MBrace Therapeutics at?

MBrace Therapeutics is at the Series B stage.

Cite this page

Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated November 14, 2023.

MLA

"MBrace Therapeutics — Funding & Investors." VCBacked, November 14, 2023, https://www.vcbacked.co/company/mbrace-therapeutics. Accessed June 30, 2026.

APA

VCBacked. (2023). MBrace Therapeutics — Funding & Investors. Retrieved June 30, 2026, from https://www.vcbacked.co/company/mbrace-therapeutics

Wikipedia (cite web)

{{cite web |title=MBrace Therapeutics — Funding & Investors |url=https://www.vcbacked.co/company/mbrace-therapeutics |website=VCBacked |access-date=June 30, 2026}}

Profile data sourced and verified per the VCBacked methodology. Last funding round dated November 14, 2023.